SCHEMBL255900

SCHEMBL255900

Cc1ccc(-c2c[nH]c3cc(C(=O)O)ccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 1/20 0.56
PRKAG1 P54619 1/20 0.56
PRKAA2 P54646 1/20 0.56
PRKAA1 Q13131 1/20 0.56
PRKAG3 Q9UGI9 1/20 0.56
PRKAG2 Q9UGJ0 1/20 0.56
PRKAB1 Q9Y478 1/20 0.56
IMPDH2 P12268 1/20 0.53
PTPN1 P18031 1/20 0.51
AURKA O14965 1/20 0.48
TPX2 Q9ULW0 1/20 0.48
MMP2 P08253 1/20 0.46
ASH1L Q9NR48 2/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TDO2 P48775 5/20 0.45
CAMKK2 Q96RR4 2/20 0.45
MAPK1 P28482 1/20 0.45
MAP2K4 P45985 1/20 0.45
MAPKAPK3 Q16644 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29221022 0.88 PRKAB2 (0.52) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL179165 0.86 PTPN1 (0.61) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL145885 0.85 TDO2 (0.57) PTPN1AURKATPX2TDO2MAPK1
SCHEMBL120467 0.82 MEN1 (0.51) IMPDH2PTPN1AURKATPX2ALDH1A1
SCHEMBL18509943 0.81 MEN1 (0.53) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL1664426 0.79 IMPDH2 (0.60) IMPDH2PTPN1AURKATPX2MMP2
SCHEMBL20451398 0.79 TDO2 (0.64) TDO2MAPK1MAP2K4MAPK6IDO1
SCHEMBL1552893 0.78 PDE4A (0.53) PTPN1ALDH1A1KDM4EHPGD
SCHEMBL30159543 0.78 PDE4A (0.53) PTPN1ALDH1A1KDM4EHPGD
SCHEMBL122574 0.78 MMP2 (0.56) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030907-A1 DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2012-03-08 WO disclosed